论文部分内容阅读
10名成人中就会有1例糖尿病患者;10例糖尿病患者中只有3例经过治疗后血糖控制达标(HbA_1c<6.5%),这是我国内分泌医生所面对的现状和挑战。因此,优化糖尿病治疗策略以提高患者的降糖达标率刻不容缓。当前,胰岛素的选择和应用是优化2型糖尿病(T2DM)治疗策略的重要一环。越来越多的证据显示,早期胰岛素治疗不仅改善β细胞功能,提高降糖达标率,而且可以延缓糖尿病并发症
One out of 10 adults had diabetes mellitus. Only 3 of 10 diabetic patients achieved glycemic control after treatment (HbA_1c <6.5%), which is the current situation and challenge for endocrinologists in China. Therefore, the optimization of diabetes treatment strategies to improve the patient’s hypoglycemic compliance rate without delay. Currently, the selection and use of insulin is an important part of optimizing the strategy for treating type 2 diabetes (T2DM). More and more evidence shows that early insulin treatment not only improve β-cell function, improve the rate of hypoglycemic compliance, but also can delay the complications of diabetes